Keywords: strong, third, quarter, genzyme, gaap, net, income
Strong third quarter for Genzyme: GAAP net income reaches $159M on the back of good sales
Article | 05 November 2007
US biotechnology major Genzyme's third-quarter 2007 profit was driven by strong product sales and continued operating leverage. The firm's income grew 19% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
